SH

Soren Hostrup

Active Director Director DIN 10724148
DIN 10724148 First appointment Aug 2024 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Soren Hostrup

Data last updated:

Soren Hostrup is a Director at Xellia Pharmaceuticals Private Limited (since 2024). The company operates in Business Services. Xellia Pharmaceuticals Private Limited reported revenue of ₹28.32 Cr (FY 2025).

DIN 10724148
Primary Designation Director
Industry Business Services
First Appointment 20 Aug 2024
Oldest Company Age 16 yrs
Largest company Xellia Pharmaceuticals Private Limited · ₹28.32 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20242010₹28.32 Cr (FY 2025)Active

Board colleagues of Soren Hostrup

Directorship timeline

Open interactive timeline →
Xellia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Soren Hostrup

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soren Hostrup

Soren Hostrup currently holds 1 directorship: Xellia Pharmaceuticals Private Limited (Director, since 20 Aug 2024, revenue ₹28.32 Cr (FY 2025)).

Soren Hostrup was first appointed on 20 Aug 2024 as Director at Xellia Pharmaceuticals Private Limited.

The current boards of Soren Hostrup's companies include Eva Blem (Xellia Pharmaceuticals Private Limited), Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada (Xellia Pharmaceuticals Private Limited), Per Bork Eppers (Xellia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available